Showing results (341-350 of 569) with videos related to

Sort By:
Pageof 57
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 5, 2011
Assessment of hepatocyte growth factor in ovarian cancer mortalityEllen L Goode, Georgia Chenevix-Trench, Lynn C Hartmann, et al.
Human Mutation|May 22, 2019
BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestryTara M Friebel, Irene L Andrulis, Judith Balmaña, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2021
Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk ScoreChi Gao, Eric C Polley, Steven N Hart, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2026
Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort studyCarlotta Becherini, Eva Blondeaux, Virginia Delucchi, et al.
International Journal of Cancer|July 4, 2017
Gene-environment interactions involving functional variants: Results from the Breast Cancer Association ConsortiumMyrto Barrdahl, Anja Rudolph, John L Hopper, et al.
Endocrine-Related Cancer|October 2, 2013
Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction studyAnja Rudolph, Rebecca Hein, Sara Lindström, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Association of Gene Variant Type and Location with Breast Cancer Risk in the General PopulationMwangala P Akamandisa, Nicholas J Boddicker, Siddhartha Yadav, et al.
BMC Medicine|July 4, 2015
Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosisMarcelo Sobral-Leite, Jelle Wesseling, Vincent T H B M Smit, et al.
International Journal of Epidemiology|January 10, 2018
Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association ConsortiumAnja Rudolph, Minsun Song, Mark N Brook, et al.
EMBO Molecular Medicine|February 17, 2022
A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasisLucía Zhu, Diana Retana, Pedro García-Gómez, et al.
Pageof 57